Home » Topics » Regulatory

Regulatory
RSS

FDA approves QVAR Inhalation Aerosol for treatment of asthma

Sep. 20, 2000

New formulation of Zyprexa introduced for psychotic disorders and manic episodes

Sep. 20, 2000

Glaxo Wellcome seeks new indication for Relenza

Sep. 19, 2000

New HIV treatment option approved by FDA

Sep. 19, 2000

New therapy for AIDS wasting receives orphan product designation from E.C.

Sep. 15, 2000

Nebulized heparin reduces airways inflammation, improves spirometric parameters in asthma

Sep. 14, 2000

Priority review granted to Femara as first-line breast cancer therapy

Sep. 13, 2000

AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder

Sep. 13, 2000

Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program

Sep. 8, 2000

Combination approved for second-line treatment of hypertension

Sep. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...